SU1553129A1 - Method of treating algomenorrhea - Google Patents

Method of treating algomenorrhea Download PDF

Info

Publication number
SU1553129A1
SU1553129A1 SU853957324A SU3957324A SU1553129A1 SU 1553129 A1 SU1553129 A1 SU 1553129A1 SU 853957324 A SU853957324 A SU 853957324A SU 3957324 A SU3957324 A SU 3957324A SU 1553129 A1 SU1553129 A1 SU 1553129A1
Authority
SU
USSR - Soviet Union
Prior art keywords
algomenorrhea
treating
days
side effects
onset
Prior art date
Application number
SU853957324A
Other languages
Russian (ru)
Inventor
Наталия Львовна Лузина
Евгений Васильевич Никушкин
Георгий Николаевич Крыжановский
Original Assignee
Научно-Исследовательский Институт Общей Патологии И Патологической Физиологии Амн Ссср
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Общей Патологии И Патологической Физиологии Амн Ссср filed Critical Научно-Исследовательский Институт Общей Патологии И Патологической Физиологии Амн Ссср
Priority to SU853957324A priority Critical patent/SU1553129A1/en
Application granted granted Critical
Publication of SU1553129A1 publication Critical patent/SU1553129A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относитс  к гинекологии. Цель изобретени  - устранение побочного действи . Дл  чего больной ввод т альфа-токоферол в дозе 300 мг/сут за 3-4 дн  до начала менструации в течение 5-7 сут. Предлагаемый способ позвол ет исключить побочные действи .This invention relates to gynecology. The purpose of the invention is to eliminate side effects. For this, the patient was administered alpha-tocopherol at a dose of 300 mg / day for 3-4 days before the onset of menstruation for 5-7 days. The proposed method allows to eliminate side effects.

Description

Изобретение относитс  к медицине, а именно к гинекологии.The invention relates to medicine, namely to gynecology.

Цель изобретени  - устранение побочного действи  лекарственных препаратов.The purpose of the invention is to eliminate the side effects of drugs.

Способ осуществл ют следующим образом .The method is carried out as follows.

Больной ввод т альфа-токоферол в дозе 300 мг за 3-4 дн  до начала менструации в течение 5-7 дней.The patient is administered alpha-tocopherol at a dose of 300 mg 3–4 days before the onset of menstruation for 5–7 days.

Пример. Больна  У., 20 лет. Поступила с диагнозом хронический правосторонний аднексит генитальный инфантилизм. Больна в течение года, получала противовоспалительную терапию в стационаре. Альгомено- ре  с момента менархе, боль возникает перед мес чными и в первый день мес чных, с начала заболевани  аднекситом боль стала более интенсивной. Принимала альфа- токоферол за 5 дней до предполагаемого начала менструаций по 300 мг в сутки. Мес чные прошли безболезненно.Example. Sick U., 20 years. He was admitted with a diagnosis of chronic right-sided adnexitis, genital infantilism. Ill for a year, received anti-inflammatory therapy in the hospital. Since the menarche, the pain occurs before the month and on the first day of the month, with the onset of adnexitis, the pain has become more intense. She took alpha-tocopherol 5 days before the expected onset of menses, 300 mg per day. Monthly passed painlessly.

Предлагаемым способом было проведено лечение 53 женщинам, при этом побочных реакций не отмечалось.The proposed method was treated 53 women, while adverse reactions were noted.

Claims (1)

Формула изобретени Invention Formula Способ лечени  альгоменореи путем введени  лекарственных средств, отличающийс  тем, что, с целью устранени  побочного действи , ввод т альфа-токоферол в дозе 300 мг за 3-4 дн  до начала менструации в течение 5-7 дней.A method of treating algomenorrhea by administering drugs, characterized in that, in order to eliminate side effects, alpha-tocopherol is administered in a dose of 300 mg 3–4 days before the onset of menstruation within 5-7 days. « (/"(/ СП СПJV JV ооoo 1чЭ1HE соwith
SU853957324A 1985-09-25 1985-09-25 Method of treating algomenorrhea SU1553129A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU853957324A SU1553129A1 (en) 1985-09-25 1985-09-25 Method of treating algomenorrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU853957324A SU1553129A1 (en) 1985-09-25 1985-09-25 Method of treating algomenorrhea

Publications (1)

Publication Number Publication Date
SU1553129A1 true SU1553129A1 (en) 1990-03-30

Family

ID=21198723

Family Applications (1)

Application Number Title Priority Date Filing Date
SU853957324A SU1553129A1 (en) 1985-09-25 1985-09-25 Method of treating algomenorrhea

Country Status (1)

Country Link
SU (1) SU1553129A1 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Кацулов А. Г. и др. Акушерство и гинекологи . 1981, Т. 20, № 6, с. 467-470. *

Similar Documents

Publication Publication Date Title
Duffy et al. Peripheral neuropathy in Crohn's disease patients treated with metronidazole
BR9306841A (en) Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment
RU95101385A (en) Products containing g-csf and tnf-binding protein
SU1553129A1 (en) Method of treating algomenorrhea
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
EG17992A (en) Preparation of a medicament for arthritis and theumatism
SU1105202A1 (en) Method of treatment of gastric ulcer and duodenal ulcer
SU1196002A1 (en) Method of treatment of chronic salpingo-oophoritis
SU1706624A1 (en) Method for curing opiumism and morphinism
DE69330809T2 (en) Therapeutic agent for neutropenia
SU1487907A1 (en) Method of treating ovular paints
Christian Treatment of muscle spasms with oral dantrolene sodium
Paller et al. Meclofenamate for psoriasis
SU1351605A1 (en) Method of treatment of sclerocystic ovarium
SU1139436A1 (en) Method of treatment of recurring herpes
SU1680172A1 (en) Method for stimulating the acupuncture points
RU2000785C1 (en) Method for therapy of candidiasis of oral mucosa
SU1745267A1 (en) Method for treatment of duodenal peptic ulcer in females
RU1822775C (en) Method for treatment of trigeminal nerve neuralgia
RU93044773A (en) METHOD FOR TREATING DISORDERS OF THE MENSTRUAL CYCLE
SU1261670A1 (en) Method of treatment of patients ill with chronic furunculosis
SU1034741A1 (en) Tuberculosis treatment method
RU1811404C (en) Zoonotic dermal leishmaniasis treatment method
SU1176899A1 (en) Method of stimulation of the function of adrenal cortex
RU1821218C (en) Antiepileptic drug for treating spasticless forms of epilepsy